This report from Life Science Intelligence provides an analysis of the global market for oncology embolization agents, including radioembolization, chemoembolization and particle embolization devices. These solutions are used to occlude blood vessels to lesions and tumors to derive the target of nutrients, enhance the effectiveness of the targeted delivery of pharmaceuticals, and trigger cell death.
This market snapshot is intended to provide a high-level overview of the global oncology embolization agents market, with key insights into:
ArtVentive Medical
Boston Scientific
Embolx
Fluidx Medical Technology
Instylla
Merit Medical
Sirtex Medical
Stryker
Terumo